Accueil › Lymphome › New York › New York City
Essais cliniques pour Lymphome à New York City, NY
33 études pour Lymphome recherchent des participants dans et autour de New York City (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Recrutement en coursPhase 1
- Columbia University, New York
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Recrutement en coursPhase 2
- Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Recrutement en coursPhase 1
- Memorial Sloan Kettering Cancer Center, New York
Epco, Zanu, Ritux for R/R FL or MZL
Recrutement en coursPhase 2
- Memorial Sloan Kettering Cancer Center, New York
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
Recrutement en coursPhase 2
- Memorial Sloan Kettering Cancer Center, New York
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
Recrutement en coursPhase 1
- Memorial Sloan Kettering Cancer Center, New York
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
Recrutement en coursPhase 1
- Cornell, New York
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Recrutement en coursPhase 1/2
- Research Site, New York
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Recrutement en coursPhase 1/2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
Recrutement en coursPhase 1
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Recrutement en coursPhase 1/2
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
Recrutement en coursPhase 2
- Memorial Sloan Kettering Cancer Center, New York
DALY II USA/ MB-CART2019.1 for DLBCL
Recrutement en coursPhase 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)
Recrutement en coursPhase 1
- Memorial Sloan Kettering, New York
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Recrutement en coursPhase 1/2
- Call for Information (Investigational Site 0031), New York
CD4CAR for CD4+ Leukemia and Lymphoma
Recrutement en coursPhase 1
- Albert Einstein Health Network, New York
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Recrutement en coursPhase 1/2
- Dren Investigational Site 1, New York
- Dren Investigational Site 2, New York
A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)
Recrutement en coursPhase 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Recrutement en coursÉtude observationnelle
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)
Recrutement en coursPhase 2
- Columbia University Irving Medical Center, New York
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
Recrutement en coursVolontaires sains bienvenus
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
Recrutement en coursPhase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Recrutement en coursPhase 1/2
- Mt Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
Study of CAR-T Therapy in Older Patients
Recrutement en coursÉtude observationnelle
- Memorial Sloan Kettering Cancer Center, New York
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Recrutement en coursPhase 2
- Memorial Sloan Kettering, New York
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
Recrutement en coursPhase 2
- Icahn School of Medicine at Mount Sinai, New York
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
Recrutement en coursPhase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Recrutement en coursÉtude observationnelle
- Memorial Sloan Kettering Cancer Center, New York
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
Recrutement en coursPhase 2
- Memorial Sloan Kettering Cancer Center, New York
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Memorial Sloan Kettering Cancer Center, New York
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
Recrutement en cours
- Columbia University, New York
CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
Recrutement en coursPhase 1
- Columbia University Irving Medical Center, New York
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Recrutement en cours
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York
Essais pour Lymphome dans d'autres villes
- Houston, TX34 études
- Boston, MA33 études
- Washington, DC23 études
- Baldwin Park, CA21 études
- Chicago, IL20 études
- Durham, NC17 études
- St. Louis, MO15 études
- Philadelphia, PA15 études
- Cleveland, OH14 études
- Edison, NJ12 études
- Seattle, WA12 études
- Atlanta, GA12 études
Autres études à New York City
- Cancer du sein136 études
- Cancer du poumon non à petites cellules121 études
- Cancer (tous types)109 études
- Cancer de la prostate103 études
- Cancer métastatique93 études
- Cancer colorectal78 études
- Cancer de l'ovaire69 études
- Cancer du poumon60 études
- Myélome multiple60 études
- Cancer du pancréas60 études
- Cancer de l'endomètre52 études
- Leucémie aiguë myéloïde51 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.